Defining the first bona fide cell model for SMARCA4-deficient, undifferentiated tumor.

Arenas, Alberto M; Ruiz-Jiménez, José Manuel; López-Hidalgo, Javier L; Sanjuán-Hidalgo, Juan; Medina, Pedro P

Arenas, Alberto M; Ruiz-Jiménez, José Manuel; López-Hidalgo, Javier L; Sanjuán-Hidalgo, Juan; Medina, Pedro P.

Afiliação

Arenas AM; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain.
Ruiz-Jiménez JM; GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
López-Hidalgo JL; Health Research Institute of Granada (ibs.Granada), Granada, Spain.
Sanjuán-Hidalgo J; GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.
Medina PP; FIBAO, Fundación Pública para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, Granada, Spain.

J Pathol ; 261(1): 5-10, 2023 09.

Article em En | MEDLINE | ID: mdl-37352131

Assuntos

Adenocarcinoma de Pulmão; Adenocarcinoma; Neoplasias Pulmonares; Tumor Rabdoide; Animais; Camundongos; Adenocarcinoma/patologia; Biomarcadores Tumorais/análise; Neoplasias Pulmonares/genética; Neoplasias Pulmonares/patologia; Mutação; Tumor Rabdoide/patologia

Palavras-chave

SMARCA2; SMARCA4; SWI/SNF; adenocarcinoma of lung; biologic model; cell culture; cell line; lung cancer; rhabdoid tumor; undifferentiated carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Tumor Rabdoide / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google